The QualityStocks Daily Friday, November 15th, 2019

Today's Top 3 Investment Newsletters

BUYINS.NET (AIHS) +154.82%

QualityStocks (BTTR) +90.84%

StockMarketWatch (TKKS) +65.63%

The QualityStocks Daily Stock List

Balmoral Resources Ltd. (BALMF)

OTC Markets, Junior Mining Network, Mining Feeds, Trading View, Wallet Investor, News Scanner, Mining.com, Proactive Investors, GlobeNewswire, Northern Miner, InvestorsHub, Metals News, Investing.com, Market Screener, Resource World, Mining Atlas, Stockhouse, and Streetwise Reports reported earlier on Balmoral Resources Ltd. (BALMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Balmoral Resources Ltd. is an exploration company exploring a portfolio of gold and base metal properties positioned within the prolific Abitibi greenstone belt. Its flagship, 1,000 km2 Detour Gold Trend Project hosts the resource-stage Bug and Martiniere West gold deposits and the Grasset nickel-copper-cobalt-PGE deposit. Balmoral Resources is based in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQX.

Balmoral has dual exposure to the gold and nickel sulphide markets. Its gold projects consist of Martiniere, Northshore, N2, Lynx-Rambo, Lac Du Doight, Grasset Gold, Area 52 (Fenelon), Detour Trend, and Vortex Ext. Its nickel projects consist of Grasset, GUC Central, Gargoyle, RUM, Goblin, and Ghost.

Grasset is a Nickel-Copper-Cobalt- PGE Deposit. It is the most advanced of the nickel discoveries made by Balmoral Resources in the Grasset Ultramafic Complex. The Project is 100 percent owned by Balmoral - royalty free. 2018 drilling extended the H1 Zone of the deposit to 800 vertical meters (an increase of more than 300 meters) and planned winter 2020 drilling will target the H3 Zone to a similar depth.

The Grasset Nickel Deposit features some of the highest tenor (nickel content) sulphides in Canada. This allows it to produce very high nickel grades. Balmoral Resources earlier announced additional discoveries within the Grasset Ultramafic Complex 7 km to the NW. At the Grasset Nickel Deposit, nickel, copper, cobalt, platinum and palladium are all considered recoverable and payable.

Balmoral Resources announced this past August that, following the recent discovery of precious metal-rich nickel sulphide mineralization on its RUM North Property, it has acquired by staking three new nickel sulphide targets similar to the intrusion hosting the Bluenose discovery. The Company now controls 15 individual ultramafic intrusive targets, covered by six separate properties, in the Lac Rocher nickel district in Central Quebec.

Balmoral Resources recently announced the first indications of nickel sulphide mineralization on its RUM project in Quebec (NR19-13 - July 30, 2019). The Company advised that follow-up hand stripping and sampling has considerably expanded the Bluenose Nickel-Copper-Gold-PGE Zone. It has confirmed the precious metal rich nature of this new nickel sulphide discovery.

The Bluenose discovery is situated on the Company’s 100 percent held RUM North Property in the Lac Rocher nickel district of Quebec. Bluenose is one of 16 untested magmatic nickel sulphide targets recently acquired by Balmoral Resources in the Lac Rocher district.

Balmoral Resources Ltd. (BALMF), closed Friday's trading session at $0.1802, off by 1.5838%, on 77,658 volume with 12 trades. The average volume for the last 3 months is 104,756 and the stock's 52-week low/high is $0.065700002/$0.195999994.

chart

Canacol Energy Ltd. (CNNEF)

Zacks, Stock Muse, GlobeNewswire, InvestorsHub, Wallet Investor, StreetWise Reports, Morningstar, TradingView, Stockhouse, TMXmoney, Investing.com, and Market Screener reported earlier on Canacol Energy Ltd. (CNNEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Canacol Energy Ltd. chiefly explores for, develops, and produces petroleum and natural gas in Colombia. The Company is a foremost natural gas exploration and production enterprise in Colombia. As of December 31, 2018, it had a total proved plus probable reserves of 98,050 one thousand barrels of oil equivalent. OTCQX-listed, Canacol Energy is headquartered in Calgary, Alberta.

Canacol Energy earlier announced that the works associated with the expansion of the gas pipeline between its operated Jobo gas processing facility and Cartagena has been completed. The works included the laying of 85 kilometers of 20 inch pipeline and the installation of additional compression. This resulted in an increase of 100 MMscfpd of transportation capacity for Canacol to its clients in Cartagena.

Last week, Canacol Energy reported its financial and operating results for the three and nine months ended September 30, 2019. Realized contractual natural gas sales grew 27 percent and 17 percent to 146.4 MMscfpd and 129.7 MMscfpd for the three and nine months ended September 30, 2019, versus 115.3 MMscfpd and 111.2 MMscfpd for the same periods in 2018, respectively.

Average natural gas production volumes increased 28 percent and 18 percent to 147.6 MMscfpd and 130.9 MMscfpd for the three and nine months ended September 30, 2019, versus 114.9 MMscfpd and 110.6 MMscfpd for the same periods in 2018, respectively. Total natural gas revenue, net of royalties and transportation expenses for the three and nine months ended September 30, 2019, increased 25 percent and 19 percent to $55.1 million and $148.2 million, versus $43.9 million and $125 million for same periods in 2018, respectively, primarily attributable to the increase of natural gas production.

The expansion of the Promigas 100 MMcfpd pipeline expansion was completed. In addition, the Jobo 3 natural gas processing facility started operation during the three months ended September 30, 2019, lifting Canacol Energy’s natural gas treatment capacity from earlier levels of 200 MMcfpd to 330 MMcfpd.

For the rest of this year, Canacol Energy is concentrating on executing its exploration drilling program and executing the required agreements related to the construction of a new gas pipeline to Medellin. This pipeline will transport 100 MMcfpd of new gas sales in 2023.

Canacol Energy Ltd. (CNNEF), closed Friday's trading session at $3.58, up 0.84507%, on 3,100 volume with 15 trades. The average volume for the last 3 months is 19,706 and the stock's 52-week low/high is $2.63000011/$3.96000003.

chart

Elron Electronic Industries Ltd. (ELRNF)

Zacks, Last10k, TMXmoney, Research and Markets, OTC Markets, Proactive Research, PR Newswire, Morningstar, Nasdaq, and Stockhouse reported earlier on Elron Electronic Industries Ltd. (ELRNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Elron Electronic Industries Ltd.’s vision is identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders. The Company, by way of its subsidiaries, provides technology products in the medical devices and cyber fields. Elron has substantial holdings in a select number of start-up companies with disruptive potential. Since 1962, Elron has been at the vanguard of Israeli innovation, as founders and early investors in companies such as Elbit Systems, Elscint, Zoran, Partner, Netvision and Given Imaging. Elron Electronic Industries has its corporate headquarters in Tel Aviv, Israel.

The Company invests mainly in early stage ventures with significant exit potential, in which it seeks significant shareholder stakes, enabling Elron to provide hands-on support and contribute from its experience. Regarding Medical Devices, the Company invests in treatment-changing (rather than treatment-enhancing) medical device enterprises. Elron looks for companies with billion-$ market potential and typically invests in the idea/R&D stage.

Concerning the Cyber field, Elron invests in exceptional ideas and technologies with the potential to transform or create new markets, and help make the world a more secure place to live in. The Company looks for investment opportunities from seed to growth stages.

Elron Electronic Industries offers BrainsGate, a minimally invasive treatment for ischemic stroke; Pocared, an automated microbiology lab system for infectious diseases diagnosis; CartiHeal implants for cartilage and bone repair in weight bearing joints; Coramaze, a transfemoral mitral valve repair system with atraumatic anchoring; Notal Vision, a remote monitoring of patients at risk of vision loss from age-related macular degeneration; cyber intelligence platform that detects and defuses threats before they become cyberattacks; and Alcide, a dev-to-production security tool for workloads running on kubernetes platforms.

The Company also offers SecuredTouch a behavioral biometrics for mobile transactions. In addition, it provides Ironscales, an automated phishing prevention, detection, and response platform; Cynerio, a connected medical device; Kindite, a cloud encryption solution; KZen, a non-custodial digital currency wallet; Naval Dome, a maritime cyber detection and prevention system; Sayata Labs, an AI-based cyber risk assessment solution; OpenLegacy, a platform that enables the digital transformation process; and OzCode, which provides root cause analysis, collaboration, and real-time bug triage solutions.

Furthermore, Elron offers PLYmedia, a platform for ad networks; Audioburst, an AI-powered audio search platform; Aqwise, a biological water and wastewater treatment solutions for the industrial and municipal markets; Atlantium, a water disinfection solution; SECDO, a platform that automatically detects suspicious activity, while hastening incident investigation and response; Kyma, a remote patient monitoring device; and Jordan Valley, an X-ray based metrology solutions for semiconductors process control. Elron also offers Cloudyn, Given Imaging, Sync-Rx, Wavion, Safend, Medingo, Teledata, and 3DV Systems.

Elron Electronic Industries Ltd. (ELRNF), closed Friday's trading session at $1.39, up 2.963%, on 600 volume with 2 trades. The average volume for the last 3 months is 2,090 and the stock's 52-week low/high is $1.27999997/$3.27999997.

chart

Pharmagreen Biotech, Inc. (PHBI)

Stockflare, Wall Street Researcher, Money Maker Stocks, OTC Markets, TipRanks, StreetInsider, Simply Wall St, Nasdaq, Market Screener, PR Newswire, Stockwatch, GlobeNewswire, Stockopedia, Stockhouse, TradingView, Wallet Investor, InvestorsHub, and MarketWatch reported earlier on Pharmagreen Biotech, Inc. (PHBI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pharmagreen Biotech, Inc. is a biotechnology sciences company with specialized products and services in the cannabis industry. The Company’s future brand of products will center on the manufacturing and marketing of cannabis products for the medical and recreational markets in Canada with an eye on global markets. Pharmagreen Biotech lists on the OTC Markets.

At present, the Company is in the application process for the Access to Cannabis for Medical Purposes Regulations (ACMPR) with Health Canada for its Cannabis Botany Center in Deroche, British Columbia. Services credited to Pharmagreen Biotech will include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets, and Nurseries.

Pharmagreen Biotech's mission is to advance the technology of tissue culture science and to provide the highest quality, 100 percent germ free, disease free, and all genetically the same plantlets of cannabis and other flora. This is while offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for different cannabis and horticulture plants; extraction of botanical oils chiefly CBD (cannabidiol) oil, and to deliver laboratory based services to the North American Cannabis and agriculture sectors.

Pharmagreen Biotech’s emphasis is on Biotech Sciences employing proprietary technologies and formulations in its state-of-the-art Cannabis Botany Center. The Cannabis/Botany Biotech Complex is a unique and proprietary design of a 63,000 sq. ft. building complex on 25 acres, in the small farming community of Deroche in the Fraser Valley. The building project makes use of advanced technologies in its engineering and also with its construction. This will result in a secure, uniquely advanced, eco-friendly and semi-automated tissue culture, cleanroom laboratory and research facility.

In October, Pharmagreen Biotech announced that its Canadian subsidiary, WFS Pharmagreen Inc., signed a Letter of Intent (LOI) with Carpere, Inc. for the supply of “CBD Dana” hemp starter plantlets for the 2020 farming season and beyond. Carpere owns and manages farmland, on behalf of farmers, in excess of 100,000 acres across Canada. Pharmagreen Biotech is preparing to supply up to 250,000 “CBD Dana” starter plantlets for the 2020 outdoor hemp growing season in Canada. This is while it continues with the development of its 63,000 sq. ft. Cannabis Biotech Complex and year-round Greenhouse in Deroche.

This week, Pharmagreen Biotech announced that it signed a term sheet for an Equity Purchase Agreement with Oscaleta Partners LLC. Pharmagreen notes that this should enable it to access capital over the next two years to support its present growth plans. The terms of the Equity Agreement will give Pharmagreen Biotech the right, but never the obligation, to sell to Oscaleta Partners up to Ten Million Dollars' worth of Pharmagreen Biotech's registered common stock over an anticipated two-year period at times and in amounts that Pharmagreen deems appropriate.

Pharmagreen Biotech, Inc. (PHBI), closed Friday's trading session at $0.95, up 5.5556%, on 15,195 volume with 32 trades. The average volume for the last 3 months is 3,690 and the stock's 52-week low/high is $0.649999976/$3.50.

chart

Pulse Seismic, Inc. (PLSDF)

TeleTrader, MicroSmallCap, Stock Picks Daily, StreetWise Reports, Global Banking & Finance Review, Stockhouse, Seeking Alpha, GlobeNewswire, TMXmoney, and Wallet Investor reported beforehand on Pulse Seismic, Inc. (PLSDF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Pulse Seismic, Inc. is a market leader in the acquisition, marketing and licensing of 2D and 3D seismic data to the western Canadian energy sector. It owns the largest licensable seismic data library in Canada. The data library offers oil and natural gas producers approximately 65,310 net square kilometers of 3D data and 829,207 net kilometers of 2D data. Established in 1985, Pulse Seismic is headquartered in Calgary, Alberta. The Company lists on the OTC Markets OTCQX.

The seismic data library extensively covers the Western Canada Sedimentary Basin. This Basin is where the majority of Canada’s oil and natural gas exploration and development take place. More specifically, the library covers important areas in Alberta, Northeast British Columbia and Saskatchewan, and includes portions of the Northwest Territories, Yukon, Manitoba and Montana.

Pulse Seismic continually expands its data library by purchasing data from varied sources, such as seismic acquisition companies and exploration companies. In addition, the Company expands its library through adding new data acquired via participation surveys.

The majority of Pulse Seismic’s data sets encompass the full range of prospective geological zones, unlike some data sets that focus on particular targets at specific depths. Every data set within the Company’s seismic library is usually available for a quality inspection and delivery within 24 hours.

Last week, Pulse Seismic reported its financial and operating results for the three and nine months ended September 30, 2019. Data library sales revenue was $2.5 million for the three months ended September 30, 2019 versus $1.6 million for the three months ended September 30, 2018. Data library sales revenue was $18.4 million for the nine months ended September 30, 2019 versus $5.8 million for the nine months ended September 30, 2018.

Net loss for the three months ended September 30, 2019 was $2.9 million ($0.05 per share basic and diluted) versus a net loss of $1.0 million ($0.02 per share basic and diluted) for the three months ended September 30, 2018. Net loss for the nine months ended September 30, 2019 was $2.7 million ($0.05 per share basic and diluted) versus a net loss of $2.8 million ($0.05 per share basic and diluted) for the nine months ended September 30, 2018.

Pulse Seismic, Inc. (PLSDF), closed Friday's trading session at $1.63, even for the day, on 300 volume. The average volume for the last 3 months is 8,638 and the stock's 52-week low/high is $0.995199978/$2.18000006.

chart

Surge Components, Inc. (SPRS)

Zacks, OTC Adventures, All Stocks Today, Emerging Growth, CapitalCube, Market Exclusive, Proactive Investors, TipRanks, Market Screener, Last10k, Stockhouse, and Morningstar reported beforehand on Surge Components, Inc. (SPRS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Surge Components, Inc. supplies electronic products and components. The Company is a foremost supplier of capacitors, discrete semi-conductors and audible/sounding devices. It sells its products to original equipment manufacturers (OEMs) and distributors via independent sales representatives or organizations in the USA, Canada, China and other Asian countries, South America, and Europe. Established in 1981, Surge Components has its corporate headquarters in Deer Park, New York.

The Company’s present product portfolio includes aluminum electrolytic capacitors, film capacitors, MLCC, discrete semiconductors, and switches. Surge Components’ monthly production capacity is among the largest for these products. In addition, Surge’s products are AECQ compliant for automotive applications.

The Company’s Capacitor product portfolio includes Aluminum Electrolytic Capacitors, Film Capacitors, and Ceramic Capacitors. In the Discrete Semiconductor portfolio, its strengths include General Purpose, Recovery, Schottky, Polymer ESD, and Transient Voltage Suppressors, Transistors, Diodes, and a complete line of Bridge Rectifiers.

Last month, Surge Components announced financial results for the fiscal Q3 ended August 31, 2019. The Company had Net Sales of $8.1 million, versus $9.3 million in the prior year period. It had Gross Profit of $2.4 million, versus $2.1 million, a 14.6 percent year-over-year increase, propelled by growth in sales volumes and higher profit margin product sales.

Surge’s Gross Profit Margin was 29.9 percent, versus 22.7 percent in the prior year period. The Company had Net Income available to Common Shareholders of $676,771; EPS of $0.12 versus $335,058, EPS of $0.06 in the prior period.

Ira Levy, President and Chief Executive Officer of Surge Components, said, “While profits were strong, net sales declined 12.9 percent in the third quarter due to a reduction in sales demand from certain customers in our Surge business and the loss of a customer in our Challenge division. Despite the decline in the quarter, we delivered a solid 6.1 percent increase in net sales in the first nine months, a testament to the strength of our diversified global sales channels. We also have a strong pipeline of new opportunities focused on the expansion of our international footprint that we expect to launch in the coming months.”

Surge Components, Inc. (SPRS), closed Friday's trading session at $2.38, up 4.8458%, on 200 volume with 2 trades. The average volume for the last 3 months is 1,850 and the stock's 52-week low/high is $0.610000014/$3.39499998.

chart

Texas Mineral Resources Corp. (TMRC)

StockInvest, All Penny Stocks, TipRanks, Marketwired, Street Insider, MarketBeat, OilandGas360, InvestorsHub, Stockhouse, InvestorIntel, GlobeNewswire, and Investing News reported earlier on Texas Mineral Resources Corp. (TMRC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Texas Mineral Resources Corp. targets the heavy rare earths and a variety of other high-value elements and industrial minerals. An exploration company, its emphasis is exploring and, if warranted, developing its Round Top heavy rare earth and industrial minerals project (950 acres) in Hudspeth County, Texas. The Company formerly went by the name Texas Rare Earth Resources Corp. It changed its name to Texas Mineral Resources Corp. in March of 2016. Incorporated in 1970, Texas Mineral Resources is headquartered in Sierra Blanca, Texas.

Texas Mineral Resources has established an American Mineral Reclamation subsidiary to seek out and develop lower cost projects involving metals and mineral recovery and reclamation from coal by-products, industrial wastewater, acid mine drainage and scrap metal processing. American Mineral Reclamation, along with industrial partners, is evaluating projects whose goal is the reclamation of high-value elements and industrial minerals from liquid and solid waste material.

Round Top is one of four principal rhyolite bodies, an igneous volcanic rock, making up the group of mountains known as The Sierra Blanca. Concerning the Round Top Project and PEA, the PEA has been completed based on the measured, indicated and inferred Resource Estimate Technical Report filed on December 20, 2013 by Texas Mineral Resources. The PEA and resource estimate was prepared by Gustavson Associates of Lakewood, Colorado.

The resource incorporated into the current mine plan totals 525.4mm kg of rare earth oxide (REO), with an average grade of 634 ppm total rare earth oxides (TREO). Of the TREO, about 72 percent consist of heavy rare earth oxides plus Yttrium (Y). In addition, Texas Mineral Resources plans on developing alternative sources of strategic minerals through the processing of coal waste and other related materials.

Texas Mineral Resources announced earlier this year that a consortium assembled by the Company successfully demonstrated the ability to produce manifold high-purity and separated rare earth minerals from Pennsylvania coal mining waste material. Minerals were purified to a 99.0 percent level, made available for Meeting participant inspection, and included scandium (Sc), dysprosium (Dy), neodymium (Nd), cerium (Ce) and lanthanum (La). Phase One results were reported at the Department of Energy’s 2019 Annual Project Review Meeting for Crosscutting Research, Rare Earth Elements, Gasification Systems and Transformative Power Generation on April 9, 2019 in Pittsburgh, Pennsylvania.

Last month, Texas Mineral Resources announced that it expanded its Board of Directors from five to seven members with the addition of Clark Moseley, Chief Executive Officer of NTEC and Peter Denetclaw, a Board member of NTEC.

Mr. Anthony Marchese, Chairman, said, “We are fortunate to have Clark Moseley and Peter Denetclaw join our Board of Directors. NTEC recently acquired 20 percent of TMRC through a strategic equity investment. We strongly felt that adding two NTEC board members would enable us to draw upon their decades of mining experience as we proceed with the development of our Round Top heavy rare earth and critical mineral project in Texas. Their success at NTEC will serve as a model for all of us at TMRC.”

Texas Mineral Resources Corp. (TMRC), closed Friday's trading session at $0.284, off by 2.069%, on 19,844 volume with 16 trades. The average volume for the last 3 months is 64,763 and the stock's 52-week low/high is $0.119999997/$0.565999984.

chart

Full Alliance Group, Inc. (FAGI)

Penny Stock Base, Stock Scores, TipRanks, Market Screener, StockAP, Insider Financial, StockInvest.us, Morningstar, Stockhouse, Stockwatch, GuruFocus, Clay Trader, 4-Traders, Investors Hangout, Dividend Investor, GlobeNewswire, and InvestorsHub reported earlier on Full Alliance Group, Inc. (FAGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Full Alliance Group, Inc. is a multi-faceted holding company listed on the OTC Markets. It has various interests in technology, healthcare, and nutraceuticals. Nutra Yu, Inc. is a wholly owned subsidiary of Full Alliance Group. EBO2, Inc., is also a wholly owned subsidiary of the Company. Full Alliance Group has its corporate headquarters in Palm Desert, California.

The Company’s Nutra Yu subsidiary develops, markets, and distributes a proprietary line of nutraceutical products. The EBO2 subsidiary is the provider of ''EBO2'', a modern high volume blood gas exchange unit for the treatment of 5-7 liters of blood with medical ozone. The unit allows extracorporeal blood and oxygenation and ozone exposure and blood filtration through the filter in an innovative way by using the integrated diffusing membranes within the filter fibers to trap lipids and proteins that are in excess in the venous blood supply.

The EBO2 unit is considered the world's most advanced medical ozone therapy performed today. The EBO2 procedure is a minimally invasive intravenous therapy alike to hemodialysis developed as a treatment for numerous cardiological problems, allowing the patient to avoid life threatening, highly risky, painful, costly and complicated surgeries and long recovery periods.

Full Alliance Group’s mission is to provide technologically advanced, natural, nutritional products of unrivaled formulation, and also to educate consumers and healthcare practitioners in preventative healthcare and in bio-energetic systems for integrating overall wellness. The Company’s industries include Health & Wellness, Orthomolecular Medicine, Cardiovascular Health, Traditional Chinese Medicine (TCM), Nutraceuticals, and Quantum Energetic Medicine.

This past May, Full Alliance Group announced that Nutra Yu launched new sales and marketing initiatives for its Dr. Louie Yu Formulations™ brand of proprietary nutraceutical products on several online retail platforms. Nutra Yu, Inc. was founded by Dr. Yu to further develop, market, and distribute his proprietary line of nutraceuticals. Nutra Yu's "Dr. Louie Yu Formulations" are a complete product line of inventive all-natural nutraceuticals founded on the science of Traditional Chinese Medicine (TCM), Western orthomolecular concepts, as well as modern-day physics.

Last month, Full Alliance Group announced it appointed Matthew Cook, MD, and Dr. Leonid Macheret to its Medical Advisory Board. Dr. Cook is the Founder of BioReset Medical Corporation and as acting President, operates a Regenerative Medicine and Pain Medicine practice, which provides pioneering non-surgical solutions in orthopedic medicine, sports medicine, regenerative pain medicine, and stem cell medicine.

Dr. Macheret is the Medical Director of Partners In Wellness, Inc. This is an innovative healthcare environment combining holistic healing with today's conventional medical practices. Partners In Wellness specializes in treating chronic illness and pain, fibromyalgia, chronic fatigue syndrome (CFS), nutrition, and non-surgical joint regeneration.

Full Alliance Group, Inc. (FAGI), closed Friday's trading session at $0.09043, up 61.771%, on 2,077,448 volume with 168 trades. The average volume for the last 3 months is 412,395 and the stock's 52-week low/high is $0.00455/$0.254999995.

chart

Better Choice Company, Inc. (BTTR)

InvestorsHub, Research Pool, Pot Stock News, Investors Hangout, Last10k, OTC.Watch, Trading View, YCharts, Barchart, Seeking Alpha, Market Screener, Biz Journals, The Street, Stockhouse, Simply Wall St, and Interactive Brokers reported beforehand on Better Choice Company, Inc. (BTTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Better Choice Company, Inc. focuses on the development of animals and adults health and wellness products. Recently, it entered into definitive agreements to acquire TruPet and Bona Vida. The Company previously went by the name Sport Endurance, Inc. It changed its corporate name to Better Choice Company, Inc. last month. Established in 2001, Better Choice Company is headquartered in Brooklyn, New York.

The Company’s plan is to develop and operate the hemp-derived canine cannabidiol space. Furthermore its plan is to develop dogs and cats, veterinary, livestock, and human health and wellness products. In addition, Better Choice Company intends to sell pet food products, flea and tick products, pet nutritional products, and related pet supplies through online.

TruPet is an online seller of pet foods, flea and tick products, pet nutritional products and related pet supplies. TruDog is one of the brand names. The name “TruDog” comes from founder Lori R. Taylor’s Great Dane named Truman. It is Truman’s legacy that ignited Lori’s life goal to educate fellow dog owners on the hidden costs associated with buying cheap and highly processed dog kibble.

Bona Vida is an innovative emerging CBD (cannabidiol) platform. Its emphasis is on developing a portfolio of brand and product verticals within the animal and human health and wellness space. Bona Vida’s aim is to foster a healthier, happier relationship between an individual and their pet. Bona Vida’s dedication is to help provide a state of good health and well-being to one’s pet. Bona Vida combines high quality all-natural ingredients along with CBD to help one’s pet live their happiest and healthiest life.

Last month, Better Choice Company announced that it signed a Memorandum of Understanding (MOU) with Choom Holdings, Inc. (OTCQB: CHOOF). Choom is an emerging adult and medical use cannabis company. Choom has secured one of the largest national retail networks in Canada, for the exclusive Canadian distribution rights to Better Choice’s CBD Bona Vida brand of products targeted for animal health and wellness once approved for sale in Canada.

Earlier this month, Better Choice Company announced that it signed an MOU with Nutrisur S.A. Nutrisur is a Uruguayan company dedicated to the production and commercialization of food and nutritional supplements for animals. The MOU is for the exclusive rights to develop CBD infused supplements, treats and other products for pets, based on ingredients suitable for their respective diets.

Damian Dalla-Longa, Better Choice Company’s Co-Chief Executive Officer, said, “Nutrisur has a long history in developing innovative products focused on animal nutrition. Joining forces with their experienced team to exclusively develop a range of Bona Vida branded supplements, treats and other products leveraging the Bona Vida CBD is what we consider just the beginning of a long-term synergistic relationship. We are excited to help Nutrisur enter the rapidly growing CBD market, while leveraging their established production facilities located in Uruguay. We look forward to the growth we can achieve together.”

Better Choice Company, Inc. (BTTR), closed Friday's trading session at $2.50, up 90.8397%, on 25,934 volume with 62 trades. The average volume for the last 3 months is 16,671 and the stock's 52-week low/high is $1.30999994/$13.2600002.

chart

Driven Deliveries, Inc. (DRVD)

Invest Tribune, Stock Price, Dividend Investor, GlobeNewswire, InvestorsHub, MarketWatch, Barchart, Seeking Alpha, Trading View, Last10k, Stockopedia, Simply Wall St, Stockhouse, Investors Hangout, Market Screener, Stockwatch, Financial Buzz, Research Pool, and Business Insider reported earlier on Driven Deliveries, Inc. (DRVD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2013, Driven Deliveries, Inc. is the world’s first and only publicly traded cannabis delivery company. It provides delivery services of legal cannabis products to consumers in the State of California. The Company previously went by the name Results-Based Outsourcing, Inc. It changed its name to Driven Deliveries, Inc. in September of 2018. The Company is based in San Diego, California.

Driven Deliveries’ focus is turn key delivery solutions for licensed brands and dispensaries. The Company provides legal cannabis consumers the ability to purchase and receive their marijuana in a quick and convenient way. It provides on-demand marijuana delivery, in select cities where permitted by law.

Company Management believes it is uniquely positioned to best serve the needs of the developing cannabis industry and capture significant market share within the sector. Experienced technology and cannabis executives founded Driven Deliveries.

Last month, Driven Deliveries announced the launch of its new delivery model, Driven Direct. This will allow the Company to work directly with brands and retailers to deliver a wide spectrum of cannabis products directly to consumers. The Company will be launching with manifold retail partners in California. In addition, Driven Deliveries will offer delivery throughout the state encompassing major metro centers and the majority of the population.

Driven Direct’s structure will be similar to that of Amazon’s delivery model. The design of program is to enable entrepreneurs to run their own local delivery networks featuring the Driven Deliveries logos.

Each delivery unit will start its day at a designated Driven station in California. There, packages ordered from local retailers are subsequently picked up by Driven Deliveries drivers and delivered direct to the consumer. Location-based algorithms will ascertain which packages are sent to these delivery stations.

Today, Driven Deliveries announced that it has partnered with BLAZE, Inc. to provide a full-service technology platform for advertising, point-of-sale, customer interfacing and more. BLAZE is a foremost compliance technology platform in the cannabis industry. It has greater than 100 clients in 4 states and will be working with Driven Deliveries for cross referral opportunities for both businesses.

Driven Deliveries, Inc. (DRVD), closed Friday's trading session at $0.739, up 33.1532%, on 3,420 volume with 12 trades. The average volume for the last 3 months is 12,097 and the stock's 52-week low/high is $0.080972/$5.8499999.

chart

Bespoke Extracts, Inc. (BSPK)

Simply Wall St, Stockopedia, InvestorsHub, Wallmine, Stockhouse, Ventureline, GuruFocus, Investors Hangout, Barchart, Wallet Investor, Infront Analytics, YCharts, Market Screener, Morningstar, Market Exclusive, Marketwired, Insider Financial, and MarketWatch reported earlier on Bespoke Extracts, Inc. (BSPK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bespoke Extracts, Inc. is a producer of high quality, flavorful, hemp-derived cannabidiol (CBD) extract products. The Company established in early 2017 to introduce a proprietary line of premium quality, all-natural CBD products in the form of tinctures and capsules for the nutraceutical and veterinary markets. Bespoke Extracts is headquartered in Sunny Isles Beach, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s products are marketed as dietary supplements and distributed through the Company’s direct-to-consumers e-commerce store. Bespoke’s products are produced using pure, all natural, zero-THC phytocannabinoid-rich (PCR) hemp-derived CBD. CBD is non-psychoactive. CBD (cannabidiol) is one of over 85 cannabinoids found in cannabis. CBD is present in more significant quantities in hemp than it is marijuana.

Bespoke Extracts’ mission is to become one of the world’s most trusted sources for premium quality, all-natural, USA-grown, hemp-derived cannabidiol (CBD) products for the nutraceutical and veterinary markets. The Company strives to use only vegan, Fair Trade Certified, and organic ingredients with fast acting benefits for anyone looking for an alternative remedy. Bespoke’s farmers have been innovators in hemp agriculture, farming practices, agrotech, as well as production for generations. Bespoke’s hemp is stable, high in CBD, low in THC, and resistant to pathogens and pests.

The Company’s products include Sport Lemon Lime Tincture – THC Free 1500MG; CBD Manuka Honey Tincture; and CBD Bacon Flavored Pet Tincture. Moreover, products include CBD Softgel Capsules; CBD Pain Relief Cream; and CBD Isolate Powder.

Bespoke Extracts announced this past November that its Board of Directors appointed Niquana (Nikki) Noel as President and Chief Executive Officer (CEO), effective immediately. Serving Bespoke as its Operations Manager, Noel assumed day-to-day leadership of the Company and joined its Board of Directors. Noel has spent close to two decades working with privately-held and publicly-traded micro and small cap companies.

Bespoke Extracts, Inc. (BSPK), closed Friday's trading session at $0.015, up 66.6667%, on 36,100 volume with 5 trades. The average volume for the last 3 months is 36,306 and the stock's 52-week low/high is $0.007899999/$0.137749999.

chart

Empire Diversified Energy, Inc. (MPIR)

PennyStockHub, Equity Net, Otc Dynamics, Hot Penny Stocks, MarketWatch, Penny Stock Tweets, Dividend Investor, Biz Journals, OTC Markets, InvestorsHub, Morningstar, Investing, Stockhouse, Stockopedia, YCharts, and Investors Hangout reported beforehand on Empire Diversified Energy, Inc. (MPIR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Empire Diversified Energy, Inc.’s primary goal is to serve the challenges of the energy Industry with inventive solutions mainly related to the safe removal and disposal of Coal Combustion Residue (CCR), typically referred to as coal ash, from the nation’s utilities storage ponds. Fundamentally, the Company’s mission is to help clean up the existing environment and develop clean fuel sources in the future. Empire specializes in Diversified Green Energy projects. It is a full-service business. OTCQB-listed, Empire Diversified Energy is based in Fort Lauderdale, Florida.

The Company is currently initiating coal-reduction strategies involving increased use of sustainable biomass. Furthermore, Empire’s longer-term plans will be to diversify into zero-emission fuel science and the broad use of economically-viable hydro-electric, solar, and wind technologies. Empire provides strategic consulting and unique environmental solutions to address industry issues including the CCR remediation and renewable energy alternatives. The Company has identified a niche market opportunity in the fly ash remediation sector.

Empire plans to acquire certain assets. These include, but are not limited to, logistical equipment, coal mines, landfills, solar equipment, and biomass inventories. This is because it is working to implement a vertical integration strategy. It is now developing a hybrid alternative fuel pellet (HAFP). The intention of HAFP is to permit utilities and other enterprises that now burn solid and gaseous fuel sources to transition from these traditional sources to HAFP’s. Empire is also developing its own proprietary binding agent. This binding agent will allow HAFP’s to be used across a broader array of platforms.

This past November, Empire Diversified Energy announced that it received the first tranche of investment funds from a private equity group. The funds were used to pay off existing debt related to the Dickerson site in Cadiz, Ohio and to expand operations at the site. This funding retired the remaining debt on the site, which was acquired with the purchase of 100 percent of the membership rights of DTE Dickerson LLC. A Michigan LLC in April of 2017. This financing also provides much needed working capital to expand the reclamation project.

Empire Diversified Energy, Inc. (MPIR), closed Friday's trading session at $0.55, up 566.6667%, on 150 volume with 2 trades. The average volume for the last 3 months is 1,233 and the stock's 52-week low/high is $0.082500003/$2.00.

chart

MMEX Resources Corp. (MMEX)

Discovery Stocks, HydroCarbonProcessing, Investors Hangout, MarketWatch, MicroCapDaily, Stockhouse, Business Wire, 4-Traders, InvestorsHub, Morningstar, OTC Markets, and Wallet Investor reported earlier on MMEX Resources Corp. (MMEX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MMEX Resources Corp. focuses on the acquisition, development and financing of oil, gas, refining and infrastructure projects in Texas and South America. The Company established to engage in the exploration, extraction, refining and distribution of oil, gas, petroleum products and electric power. A development-stage company, MMEX Resources is headquartered in Fort Stockton, Texas.

MMEX’s main areas of interest include the acquisition and potential development of refining, oil & gas assets in Texas, and the acquisition of oil and gas properties in Peru. In addition, main areas of interest include crude, oil and product export opportunities in Latin America, and the development of terminals, storage, refining, oil & gas in Brazil.

The Company’s projects include the Pecos County Refinery Project, Fort Stockton, Texas. Phase 1 of this project is a 10,000 BPD Crude Distillation Unit. Phase 2 is a 100,000 BPD Large-Scale Refinery. The project is in Sulfur Junction, about 20 miles northeast of Fort Stockton. The project is strategically positioned close to oil production in West Texas, with storage capability.

MMEX Resources signed an off-take agreement with Pilot Thomas Logistics. The off-take agreement is for the sale of its diesel fuel production from Phase 1 of the MMEX refinery project in Pecos County. In November 2017, MMEX Resources broke ground on Phase 1 of the MMEX Refinery Project in Pecos County. The agreement provides for Pilot Thomas Logistics to obtain 100 percent of the diesel production from Phase 1, roughly 4,200 barrels per day, for markets in the Permian Basin area principally for use in drilling operations.

MMEX Resources intends to develop a solar power project to provide electric power to its planned 10,000 barrel-per-day (BPD) crude distillation unit and its full-scale crude oil refinery in Pecos County near Fort Stockton, Texas.

In October 2018, MMEX Resources and Blanchard Industrial, LLC (BIL) announced that BIL will be the overall EPC contractor to complete the detailed engineering and to construct the planned Pecos County Crude Distillation Unit refinery earlier announced by MMEX. BIL is an industry leader in design, engineering, procurement and construction (EPC) solutions.

MMEX Resources Corp. (MMEX), closed Friday's trading session at $0.0002, up 108.3333%, on 75,213,170 volume with 33 trades. The average volume for the last 3 months is 90,222,237 and the stock's 52-week low/high is $0.000000999/$0.289999991.

chart

ReelTime Rentals, Inc. (RLTR)

MarketWatch, Stockhouse, Marketwired, WalletInvestor, Penny Stock Hub, Barchart, Simply Wall St, Penny Stock Tweets, 4-Traders, InvestorsHub, and OTC Markets reported on ReelTime Rentals, Inc. (RLTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ReelTime Rentals, Inc. (d/b/a ReelTime VR, ReelTime Media Group) is a multimedia publishing business. The Company engages in helping individuals that have been thrust into the public eye to monetize their exposure and control the portrayal of their story. In addition, it develops, produces, and distributes Virtual Reality (VR) Content and technologies under the brand ReelTime VR. ReelTime is headquartered in Seattle, Washington and lists on the OTC Markets.

ReelTime has end to end production, editing, and distribution capabilities for internal and external projects. At present, the Company produces three ongoing series for the Samsung Gear VR platform, VeeR TV, Oculus. It distributes them over manifold VR delivery sites.

Regarding Partnerships, ReelTime partners with other top VR distributors, content producers, and technology providers. Furthermore, concerning its Services, the Company offers Consulting, Production, Monetization, VR Set Design, VR Media Campaigns, as well as VR Content Production.

Pertaining to VR Set Design, ReelTime has a totally-dressed virtual set in its studio facilities. It can create any look one wants for their Virtual Reality show. Also, it can provide traditional virtual set backdrops.

Concerning VR Content Production, ReelTime has a team of editors and other pre/post-production professionals available for all elements of producing VR content. This is from the initial design concepts, to pixel-perfect deliverables.

ReelTime VR announced recently that it became the first to utilize a proprietary technology developed by the Company that allows it to film in full 360 x 360 Virtual Reality formats and simultaneously film in formats compatible with traditional Television platforms. This will allow ReelTime VRs shows the Company produces to not only be available on the rapidly growing premium VR sites it is currently available on, but it will additionally be available for distribution over mainstream Network Television formats and worldwide.

ReelTime has received patent-pending status from the United States Patent and Trademark Office (USPTO) for its non-provisional patent application encompassing apparatus and method claims for technology involving simultaneous capturing of 360 X 360-degree Spherical Panorama Images and Video. The technology will enable any cell phone or other camera to promptly capture 360 X 360 Virtual Reality Video or pictures without any need for stitching.

The VR content is compatible with and can be shared through 360 capable social sites in real time, and on any professional VR platform such as Oculas, Gear VR, Veer VR, Playstation VR, Littlstar, and the HTC Vive.

ReelTime will start using this inventive technology in its production of its award-winning Virtual Reality travel series “In Front of View”. The series commenced filming its second season in Thailand in July. It is shot in English and in Thai. Moreover, ReelTime VR is entertaining licensing agreements with select other VR, film, and TV producers to allow them to also gain a competitive advantage.

ReelTime Rentals, Inc. (RLTR), closed Friday's trading session at $0.0167, up 28.4615%, on 29,982 volume with 7 trades. The average volume for the last 3 months is 154,014 and the stock's 52-week low/high is $0.002799999/$0.032000001.

chart

The QualityStocks Company Corner

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, on Thursday reported its financial and operational results for the third quarter ended September 30, 2019. Among other highlights, the company reported revenue for the third quarter of $171,003, a significant increase compared to $128,593 for the same period in 2018. To view the full press release, visit http://nnw.fm/3gqLY.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Friday's trading session at $0.79, up 5.3193%, on 232,273 volume with 492 trades. The average volume for the last 3 months is 166,807 and the stock's 52-week low/high is $0.451099991/$2.46000003.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTCQB: SGSI) is well positioned to capitalize on the impending rollout of 5G as it continues to build and service end-to-end communications networks. An article discussing the company reads, “The rollout of 5G networks is expected to create three million American jobs and add half a trillion dollars to U.S. GDP, according to global-management consultant Accenture. To view the full article, visit http://nnw.fm/ALP0j. Also today, NetworkNewsWire released a report on the company detailing how, recently added over $2.5 million in new contract awards from existing and new clients across all operating subsidiaries to its opportunity pipeline, according to a company news release (http://nnw.fm/QJl1a). The bulk of orders received is for infrastructure projects as carriers upgrade their networks in advance of the rollout of 5G in the United States.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Friday's trading session at $0.036008, up 12.525%, on 26,063 volume with 6 trades. The average volume for the last 3 months is 188,619 and the stock's 52-week low/high is $0.014999999/$0.449999988.

Recent News

chart

LiveWire Ergogenics Inc. (OTC: LVVV)

The QualityStocks Daily Newsletter would like to spotlight LiveWire Ergogenics Inc. (LVVV).

LiveWire Ergogenics (OTC: LVVV), a forward-thinking company engaged in the acquisition, licensing and management of fully compliant turnkey facilities for the production of cannabis-based products and services in California, purchased an historic Paso Robles ranch property earlier this year (http://cnw.fm/QljG1). To view the full article, visit http://cnw.fm/jrv4A. Also today, the company was highlighted in a publication from HempWireNews, examining how a moratorium on new hemp businesses has been extended till September 2020 by the Thousand Oaks City Council. Initially, the city council had banned hemp businesses on September 24 for a period of 45 days. The city council held a meeting last week where they extended the moratorium for 10 months and 15 days.

LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.

During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:

PODs and Distribution in Coachella, California

For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.

Estrella Ranch in Paso Robles, California

Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.

 

The Paso Robles Nursery

LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.

LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.

GHC Ventures Subsidiary

GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.

GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.

Research Partnerships

LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.

LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.

7X Pure™ Dosing and Verification System

LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.

The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.

The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.

Acquisitions & Operations

To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.

Market Opportunity

Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.

The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.

Business Model

LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.

Management Team

LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.

Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.

As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.

Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.

Advisory Board

Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.

Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.

Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.

Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.

LiveWire Ergogenics Inc. (OTC: LVVV), closed Friday's trading session at $0.00489, up 2.0877%, on 574,685 volume with 16 trades. The average volume for the last 3 months is 1,169,845 and the stock's 52-week low/high is $0.0038/$0.037399999.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

Los Angeles, California-based MCTC Holdings (OTC: MCTC)is an innovator in the field of cannabinoid nanoparticles and infusion technologies and holds several important cannabinoid patents filed; the company also has an active research and development program underway. To view the full article, visit http://cnw.fm/0nmEH.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Friday's trading session at $1.03, even for the day, on 2,179 volume with 8 trades. The average volume for the last 3 months is 9,532 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Diversified holdings company Sharing Services Global Corporation (OTCQB: SHRG)recently announced record first-quarter revenues, as well as cumulative sales of more than $129 million since December 2017 (http://nnw.fm/zMbX9). To view the full article, visit http://nnw.fm/4PbHK.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.125, even for the day, on 16,775 volume with 3 trades. The average volume for the last 3 months is 34,709 and the stock's 52-week low/high is $0.090000003/$0.3944.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven, precision-medicine company, applies its smart tumor profiling and artificial intelligence (“AI”) platform to extensive genomic and biomarker patient data sets to predict and improve clinical outcomes for cancer patients. An article discussing the company reads, “While precision medicine, sometimes referred to as personalized medicine, is a relatively new term, the idea has been around for years (http://nnw.fm/0gXRp). To view the full article, visit http://nnw.fm/zXx1a.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Friday's trading session at $3.845, off by 5.7598%, on 41,903 volume with 214 trades. The average volume for the last 3 months is 15,432 and the stock's 52-week low/high is $3.31999993/$8.50.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in the 420 with CNW by CannabisNewsWire. Last week, an Illinois lawmaker filed a bill that would increase access to banking services for marijuana businesses. The number of financial institutions accepting to transact with marijuana-related businesses is increasing; however, the majority are still wary of doing business with cannabis businesses while cannabis remains federally illegal.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $2.29, off by 7.2874%, on 3,467,974 volume with 10,200 trades. The average volume for the last 3 months is 1,684,561 and the stock's 52-week low/high is $2.25/$8.43999958.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the United States, recently appointed Dr. Ari Mackler as its first-ever chief scientific officer (http://cnw.fm/JCdj7). To view the full article, visit http://cnw.fm/9UksR.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday's trading session at $1.33, off by 14.1935%, on 43,851 volume with 58 trades. The average volume for the last 3 months is 37,455 and the stock's 52-week low/high is $1.33000004/$6.00810003.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1)on Thursday announced the release of its financial and operating results for the first quarter ended September 30, 2019. In addition, the company announced its entry into a credit agreement with Bank of Montreal ("BMO") as Lead Arranger and Agent on behalf of a group of lenders for $90 million of senior secured credit facilities consisting of a term loan of $70 million and a revolving credit facility of $20 million. To view the full press release, visit http://cnw.fm/D6dHj

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.5275, off by 8.6327%, on 2,274,591 volume with 923 trades. The average volume for the last 3 months is 515,820 and the stock's 52-week low/high is $0.479999989/$1.7888.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

Saskatchewan, Canada-based cannabinoid refining innovator HTC Extraction Systems (TSX.V: HTC) is anticipating the arrival of its initial new extraction equipment next month at the company’s recently completed 19,000-square-foot facility in Port Lajord, 17 miles southeast of Regina’s metropolitan commerce center. Also today, InvestorBrandNetwork released a report on the company detailing how, as the CBD market continues to swell, HTX Extraction has strategically positioned itself for success with its proprietary extraction technology. An article discussing the company reads, The U.S. CBD market alone will soar from $591 million in 2018 to a massive $22 billion by 2022, growing at a CAGR of 147% (http://cnw.fm/SD6oE). 

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Friday's trading session at $0.27, off by 1.8182%, on 139,000 volume with 14 trades. The average volume for the last 3 months is 118,418 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and China, plans to diversify revenue streams in FY2020. In a letter to shareholders, CIIX CEO Warren Wang outlined the company’s plans to focus on its core investor-relations business as well as continue to expand and market its industrial hemp-infused/CBD products in China and the United States as it eyes greater revenues and profits (http://cnw.fm/K8Tno). Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Last week, an Illinois lawmaker filed a bill that would increase access to banking services for marijuana businesses. The number of financial institutions accepting to transact with marijuana-related businesses is increasing; however, the majority are still wary of doing business with cannabis businesses while cannabis remains federally illegal.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Friday's trading session at $0.25, off by 3.8092%, on 59,050 volume with 25 trades. The average volume for the last 3 months is 43,956 and the stock's 52-week low/high is $0.165000006/$0.660000026.

Recent News

chart

Quest Patent Research Corp. (OTCQB: QPRC)

The QualityStocks Daily Newsletter would like to spotlight Quest Patent Research Corp. (OTCQB: QPRC).

New York City-based Quest Patent Research (OTCQB: QPRC)provides financial, strategic and legal resources for intellectual-property (“IP”) monetization. The company presently holds a wide-ranging portfolio of diverse assets (http://nnw.fm/Ebr0t). To view the full article, visit http://nnw.fm/z8CPo.

Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.

Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Objectives

Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:

  • IP Valuation
  • Structured Licensing Programs
  • Patent Prosecution
  • Partial or Full Liquidity
  • Portfolio Evaluation
  • Portfolio Maintenance
  • Legal Advisory
  • Attorney/Investor Referral
  • Patent Acquisition/Liquidation

At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.

Management

Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.

Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.

Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.

Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.

Quest Patent Research Corp. (OTCQB: QPRC), closed Friday's trading session at $0.01, off by 16.6667%, on 1,240,856 volume with 72 trades. The average volume for the last 3 months is 257,071 and the stock's 52-week low/high is $0.004499999/$0.039999999.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING)was featured on this week’s episode of MoneyTV with Donald Baillargeon. The program is syndicated internationally and covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. To view the full press release, visit http://cnw.fm/w7yQ4.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Friday's trading session at $0.0113, off by 6.6116%, on 3,989,505 volume with 123 trades. The average volume for the last 3 months is 2,661,549 and the stock's 52-week low/high is $0.009999999/$0.028799999.

Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Xalles Holdings (OTC: XALL), a fintech holding company, is a seasoned payment-systems and solutions builder as well as a fervent supporter of the cryptocurrency market. To view the full article, visit http://ccw.fm/LGo6v.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
All current subsidiaries are wholly owned

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Advancements in 2019

  • Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
  • Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
  • Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.

“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”

– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)

Xalles Holdings Inc. (OTC: XALL), closed Friday's trading session at $0.0029, off by 6.4516%, on 352,100 volume with 12 trades. The average volume for the last 3 months is 1,831,016 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.